Cyclin G2 inhibits the Warburg effect by blocking LDHA Y10 phosphorylation, thereby reversing the immunosuppressive microenvironment and halting tumor progression with a stronger anti-tumor effect when combined with anti-PD-177. Here, LDHA is linked to neoplasm.